ImmunoCellular Therapeutics

Region	Nordamerika
ISIN	US4525362046
Sektor	Biotechnologie
Website	http://www.imuc.com/

ImmunoCellular Therapeutics, Ltd. , based in Los Angeles, is developing immune-based therapies for the treatment of cancer. ImmunoCellular is focused on advancing its Stem-to-T-Cell research program, which engineers hematopoietic stem cells to generate cytotoxic T cells.